<DOC>
	<DOCNO>NCT00219934</DOCNO>
	<brief_summary>Group A : Long-term follow-up need subject identify acute early course HIV-1 infection , independent decision regard therapy highly active anti-retroviral therapy ( HAART ) . Group B : This protocol also offer subject diagnose acute HIV-1 infection past participate ADARC/Rockefeller University Hospital treatment protocol acute HIV-1 infection , currently viral load consistently less 50 copies/ml current treatment ( Group B )</brief_summary>
	<brief_title>Observational Study Treated Untreated Acute Early HIV-1 Infection</brief_title>
	<detailed_description>At initial visit : subject undergo complete history physical examination . They blood draw HIV-1 antibody testing , resistance testing , lymphocyte subset . In addition , blood drawn hematology , chemistry , syphilis , Hepatitis B C serology . Individuals Group B HIV-1 antibody testing , resistance testing , Hepatitis B C serology perform , would perform part current protocol . Individuals elect initiate antiretroviral therapy obtain standard HAART prescribe physician . Group A subject see Weeks 4 , 12 , every 12 week week 48 , every 24 week week 96 . If treat acute early infection , see every 48 week thereafter 5 year . If untreated acute early infection , discontinue study . Group B participant follow less 96 week see every 12 week week 48 , every 24 week week 96 . Participants currently enrol beyond week 96 treat acute early infection , whose treatment uninterrupted , see every 48 week . If participant treat acute early infection , treatment interrupt , discontinue study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Group A : HIV1 infected individual least 16 year age HIV1 RNA detectable blood ( &gt; 2000 copies/ml ) one following : 1. negative test HIV1 antibodies 2. indeterminate test HIV1 antibodies 3. positive test HIV1 antibodies immature Western Blot ( less 5 band ) subsequently mature ( addition 2 band ) 4. positive test HIV1 antibody document negative test within 6 month presentation 5. positive test HIV1 antibodies simultaneous negative low sensitivity ( `` detuned '' ) assay ( S/C &lt; 15 ) 6 . Individuals must able willing provide write informed consent Group B : Approximately 90 individual diagnose acute HIV1 infection past participate ADARC/Rockefeller University Hospital protocol involve treatment acute HIV1 infection currently regimen HIV1 RNA consistently less 50 copies/ml interested change protease inhibitorsparing regimen may continue treat medication provide take part complete ADARC/RUH study treatment acute early HIV infection Individuals le 16 year age Individuals unable unwilling provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>New HIV Infection</keyword>
	<keyword>Acute HIV Infection</keyword>
	<keyword>Primary HIV Infection</keyword>
	<keyword>Acute Seroconversion Syndrome</keyword>
</DOC>